Work

S875 The Evolution of Clinical Trial Design in Ulcerative Colitis: Interpreting Future Endpoints Based on Post-Hoc Analyses of the Vedolizumab Phase 3 Trials GEMINI 1 and VISIBLE 1

Year: 2021

Type: conference-abstract

Source: The American Journal of Gastroenterology

DOI: 10.14309/01.ajg.0000777032.10922.69

Authors: William J. Sandborn, Bruce E. Sands, Sharif Uddin, Karen Lasch, Rana Qasim Khan

Institutions: University of California San Diego, Icahn School of Medicine at Mount Sinai

Language: English

Topic: Inflammatory Bowel Disease

Subfield: Genetics

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W3210164484

Cites:

Cited by:

Related to: 10